Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports.Check Now!
ERS 2025 Conference: A Comprehensive Review and Analysis
- Home
- ERS Conference 2025
Leading Poster and Oral Presentations on IPF at ERS 2025
As ERS 2025 opens on September 27th, idiopathic pulmonary fibrosis (IPF) is poised to take the spotlight, reflecting both the urgent unmet need and the rapidly diversifying research landscape in this relentless disease.
Our Recent Articles
Types / Technology
Indications
Title
Leading Poster and Oral Presentations on IPF at ERS 2025
Summary
As ERS 2025 opens on September 27th, idiopathic pulmonary fibrosis (IPF) is poised to take the spotlight, reflecting both the urgent unmet need and the rapidly diversifying research landscape in this relentless disease.
Article Type
Clinical Trials
Title
ERS 2025 Top Abstracts: Redefining the Future of Respiratory Care with Next-Generation Therapies
Summary
Chronic respiratory diseases (CRDs) remain both underestimated and underprioritized in Europe, despite new data showing they affect nearly 82 million people and drive USD 21 billion in annual costs.
Article Type
Clinical Trials
Case Studies
Respiratory Domain Conference Coverage
Get a thorough event monitoring for a client having a portfolio around IPF.
Conference Coverage Intelligence
Discover how a mid-sized European pharma company utilized ATS 2022 conference coverage
KOL Profiling
Learn how the engagement with respected KOLs bolstered the client's reputation as a leader in the pharma industry
Due Diligence
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics
Digital Opinion Leader Analysis
Find out how a pharma company understood the landscape of DOLs in the UK related to cystic fibrosis.
Newsletter and Whitepapers
Asthma Market To Advance At a Great Extent Due To Growing Prevalence of the Disease Worldwide
Asthma is a chronic disease of the air passages characterized by inflammation and narrowing of the airways. The air passages in the lungs become narrow due to inflammation and tightening of the muscles around the small airways. Get a sneak peek of the Asthma pipeline therapies, clinical trials, deals & tie-ups, and upcoming world-class conferences, as well as track all the recent updates in the Asthma market.
-market.png&w=3840&q=75)
-market.png&w=3840&q=75)
-market.png&w=3840&q=75)
-marker.png&w=3840&q=75)
-marker.png&w=3840&q=75)
Get Expert Consultation Now!
Our extensive history and deep knowledge in the field of respiratory health make us an ideal ally for addressing your urgent business challenges.
Leveraging our comprehensive understanding of the respiratory pipeline, nuanced grasp of market dynamics, and keen insight into marketing intricacies, we can assist you in devising a highly effective strategy for future success.
Reach out to us to explore potential collaboration opportunities and learn more about the valuable solutions we can provide.
Delivering value through our expansive service offerings
Considering the ever-changing nature of the rheumatology therapy field, it's crucial to establish a competitive advantage for your business as soon as possible. Our range of consulting services and market research resources positions us well to guide you through obstacles while maximizing your strengths and opportunities.
We provide valuable insights to enhance your competitive edge and develop successful growth strategies. Join us on a journey to uncover opportunities and avoid pitfalls, as we simplify the process of optimizing your return on investment through our expert guidance.
Involve us to help you collect insights on which asset could hold the most potential in the future.
Our 10-year forecast provides foresight for effective strategy-building for successful market entry
Our research expertise delivers real-time information that elevates your business decisions
We assist in navigating the tricky drug development terrain by providing intelligence assessments